NR4A1 and breast cancer: Based on the expression of estrogen or progesterone receptor markers and human epidermal growth factor 2 (HER2), breast cancers can be divided into three categories: hormone receptor (HR)‐positive/HER2‐negative, HER2‐positive, and triple‐negative [15].